|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oversikt over luftvegsprøver, Mikrobiologisk
avdeling, HUS. |
2020-2021 |
|
|
Inneliggjande pasientar |
Veke 21-28 |
|
Veke 21-27 |
|
Veke 21-26 |
|
Veke 21-25 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
112 |
<5 |
|
|
87 |
<5 |
|
|
128 |
<5 |
|
|
113 |
<5 |
|
|
|
Bordetella parapertussis |
112 |
<5 |
|
|
87 |
<5 |
|
|
128 |
<5 |
|
|
113 |
<5 |
|
|
|
Mycoplasma pneumoniae |
112 |
<5 |
|
|
87 |
<5 |
|
|
128 |
<5 |
|
|
113 |
<5 |
|
|
|
Chlamydia pneumoniae |
112 |
<5 |
|
|
87 |
<5 |
|
|
128 |
<5 |
|
|
113 |
<5 |
|
|
|
Influensavirus A |
368 |
<5 |
|
|
315 |
<5 |
|
|
362 |
<5 |
|
|
334 |
<5 |
|
|
|
Influensavirus B |
368 |
<5 |
|
|
315 |
<5 |
|
|
362 |
<5 |
|
|
334 |
<5 |
|
|
|
Parainfluensavirus 1 |
112 |
<5 |
|
|
87 |
<5 |
|
|
128 |
<5 |
|
|
113 |
<5 |
|
|
|
Parainfluensavirus 2 |
112 |
<5 |
|
|
87 |
<5 |
|
|
128 |
<5 |
|
|
113 |
<5 |
|
|
|
Parainfluensavirus 3 |
112 |
<5 |
|
|
87 |
<5 |
|
|
128 |
<5 |
|
|
113 |
<5 |
|
|
|
Respiratorisk syncytialt virus |
188 |
<5 |
|
|
154 |
<5 |
|
|
207 |
<5 |
|
|
224 |
<5 |
|
|
|
Humant metapneumovirus |
112 |
<5 |
|
|
87 |
<5 |
|
|
128 |
<5 |
|
|
113 |
<5 |
|
|
|
Rhinovirus |
112 |
12 |
11 % |
|
87 |
<5 |
|
|
128 |
13 |
10 % |
|
113 |
9 |
8 % |
|
|
SARS-CoV-2 |
421 |
<5 |
|
|
384 |
<5 |
|
|
436 |
<5 |
|
|
400 |
<5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ambulante pasientar |
Veke 21-28 |
|
Veke 21-27 |
|
Veke 21-26 |
|
Veke 21-25 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
141 |
<5 |
|
|
162 |
<5 |
|
|
130 |
<5 |
|
|
172 |
<5 |
|
|
|
Bordetella parapertussis |
141 |
<5 |
|
|
162 |
<5 |
|
|
130 |
<5 |
|
|
172 |
<5 |
|
|
|
Mycoplasma pneumoniae |
141 |
<5 |
|
|
162 |
<5 |
|
|
130 |
<5 |
|
|
173 |
<5 |
|
|
|
Chlamydia pneumoniae |
141 |
<5 |
|
|
162 |
<5 |
|
|
130 |
<5 |
|
|
173 |
<5 |
|
|
|
Influensavirus A |
165 |
<5 |
|
|
169 |
<5 |
|
|
136 |
<5 |
|
|
183 |
<5 |
|
|
|
Influensavirus B |
165 |
<5 |
|
|
169 |
<5 |
|
|
136 |
<5 |
|
|
183 |
<5 |
|
|
|
Parainfluensavirus 1 |
141 |
<5 |
|
|
162 |
<5 |
|
|
130 |
<5 |
|
|
172 |
<5 |
|
|
|
Parainfluensavirus 2 |
141 |
<5 |
|
|
162 |
<5 |
|
|
130 |
<5 |
|
|
172 |
<5 |
|
|
|
Parainfluensavirus 3 |
141 |
<5 |
|
|
162 |
<5 |
|
|
130 |
<5 |
|
|
172 |
<5 |
|
|
|
Respiratorisk syncytialt virus |
152 |
<5 |
|
|
165 |
<5 |
|
|
132 |
<5 |
|
|
179 |
<5 |
|
|
|
Humant metapneumovirus |
141 |
<5 |
|
|
162 |
<5 |
|
|
130 |
<5 |
|
|
172 |
<5 |
|
|
|
Rhinovirus |
141 |
24 |
17 % |
|
162 |
39 |
24 % |
|
130 |
44 |
34 % |
|
172 |
43 |
25 % |
|
|
SARS-CoV-2 |
8735 |
125 |
1 % |
|
9726 |
63 |
1 % |
|
9682 |
32 |
0 % |
|
10054 |
20 |
0 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inneliggjande pasientar omfatter fleire
sjukehus i vår region |
|
|
|
|
|
|
|
23.07.2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|